Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Clinical Immunology
Erschienen in: Journal of Clinical Immunology 2/2016

01.02.2016 | Original Article

Life with a Primary Immune Deficiency: a Systematic Synthesis of the Literature and Proposed Research Agenda

verfasst von: Morgan N. Similuk, Angela Wang, Michael J. Lenardo, Lori H. Erby

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The clinical immunology literature is punctuated with research on psychosocial dimensions of illness. Studies investigating the lived experiences and stated needs of patients with primary immune deficiencies and their families are essential to improving clinical management and determining the research questions that matter to patients and other stakeholders. Yet, to move the field forward, a systematic review of literature and proposed agenda is needed.

Methods

A systematic review was conducted via PubMed and Scopus to include original research on psychological, social, or behavioral aspects of primary immune deficiencies published between 1999 and 2015. A Title/Abstract keyword search was conducted, 317 candidate article abstracts were manually reviewed, and forward/backward reference searches were completed.

Results

Twenty-nine studies met inclusion criteria. These illuminate the complex psychological, social, and emotional experiences of primary immune deficiency. Themes included the potential for negative psychosocial impact from disease; adaptation over time; the multi-dimensional assessments of quality of life; familial impact; the important roles of hope, developing a sense of control, social support; and addressing anxiety/depression in our patients and their families. Methodological considerations and areas for improvement are discussed.

Conclusion

We propose the research agenda focus on study creativity and rigor, with improved engagement with existing literature and critical study design (e.g., methodology with adequate statistical power, careful variable selection, etc.). This review highlights opportunities to advance psychosocial research and bring a brighter future to clinicians, researchers, and families affected by primary immune deficiency.
Literatur
1.
Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol. 2002;20:514–20.CrossRefPubMed
2.
van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol. 2006;24(22):3672–7.CrossRefPubMed
3.
Cukier YR, Thompson HS, Sussner K, Forman A, Jandorf L, Edwards T, et al. Factors associated with psychological distress among women of African descent at high risk for BRCA mutations. J Genet Couns. 2013;22(1):101–7.CrossRefPubMed
4.
Hoskins LM, Werner-Lin A. A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18–25. J Genet Couns. 2013;22(1):27–38.PubMedCentralCrossRefPubMed
5.
Wang JH, Schwartz MD, Brown RL, Maxwell AE, Lee MM, Adams IF, et al. Results of a randomized controlled trial testing the efficacy of a culturally targeted and a generic video on mammography screening among chinese-american immigrants. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1923–32.PubMedCentralCrossRefPubMed
6.
Rush CL, Darling M, Elliott MG, Febus-Sampayo I, Kuo C, Munoz J, et al. Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res. 2015;24(5):1107–18.CrossRefPubMed
7.
Joseph G, Beattie MS, Lee R, Braithwaite D, Wilcox C, Metrikin M, et al. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). J Genet Couns. 2010;19(5):447–62.PubMedCentralCrossRefPubMed
8.
Hollin I, Peay H, Bridges JP. Caregiver preferences for emerging Duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis. Patient. 2015;8(1):19–27.CrossRefPubMed
9.
Furlong P, Bridges JF, Charnas L, Fallon JR, Fischer R, Flanigan KM, et al. How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration. Orphanet J Rare Dis. 2015;10:82.PubMedCentralCrossRefPubMed
10.
Ingles J, Sarina T, Kasparian N, Semsarian C. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol. 2013;168(4):3779–84.CrossRefPubMed
11.
Abolhassani H, Sadaghiani MS, Aghamohammadi A, Ochs HD, Rezaei N. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol. 2012;32:1180–92.CrossRefPubMed
12.
McDowell E, Titman P, Davidson S. Parents’ experiences one year on from their child’s hematopoietic stem cell transplant for primary immunodeficiency. J Health Psychol. 2010;15:897–904.CrossRefPubMed
13.
Høybråten Sigstad HM, Stray-Pedersen A, Frøland SS. Coping, quality of life, and hope in adults with primary antibody deficiencies. Health Qual Life Outcomes. 2005;3:1–13.CrossRef
14.
Ca J, Na H, Hadley DW. Perceptions of reproductive risk and carrier testing among adolescent sisters of males with chronic granulomatous disease. Am J Med Genet C: Semin Med Genet. 2003;119C:60–9.CrossRef
15.
McKeever P, O’Neill S, Miller K-L. Managing space and marking time: mothering severely ill infants in hospital isolation. Qual Health Res. 2002;12:1020–32.CrossRefPubMed
16.
Fanos JH, Puck JM. Family pictures: growing up with a brother with X-linked severe combined immunodeficiency. Am J Med Genet. 2001;98:57–63.CrossRefPubMed
17.
Giacomini MK, Cook DJ. User’s guides to the medical literature. J Am Med Assoc. 2000;284:478–82.
18.
Piazza-Waggoner C, Aggoner C, Adams CD, Muchant D, Wilson N, Hogan MB. Children ’ s Health care children with primary immunodeficiency disorders : family functioning, coping strategies, and behavioral functioning. Children’s Health Care. 2010:37–41.
19.
Piazza-Waggoner C, Adams CD, Muchant D, Wilson NW, Hogan MB. Coping and adjustment in children with primary immunodeficiency disorders and kidney diseases: the role of illness severity. Child Health Care. 2008;37:210–24.CrossRef
20.
Ca J, Hadley DW, Na H, Ja W. How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genet Med. 2006;8:234–42.CrossRef
21.
Stephenson DD, Beaton E, Weems CF, Angkustsiri K, Simon TJ. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications. Behav Brain Res. 2014;276:190–8.PubMedCentralCrossRefPubMed
22.
Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Da W, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31:407–14.CrossRefPubMed
23.
Titman P, Allwood Z, Gilmour C, Malcolmson C, Duran-Persson C, Cale C, et al. Quality of life in children with primary antibody deficiency. J Clin Immunol. 2014;34:844–52.PubMedCentralCrossRefPubMed
24.
Jörgensen GH, Gardulf A, Sigurdsson MI, Arnlaugsson S, Hammarström L, Ludviksson BR. Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL. Qual Life Res: Int J Qual Life Asp Treat Care Rehabil. 2014;23:645–58.CrossRef
25.
Kluger N, Jokinen M, Krohn K, Ranki A. What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessment in Finnish patients. Clin Endocrinol. 2013;79:134–41.CrossRef
26.
Aghamohammadi A, Montazeri A, Abolhassani H, Saroukhani S, Pourjabbar S, Tavassoli M, et al. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol. 2011;10:47–51.PubMed
27.
Bouillet L, Launay D, Fain O, Boccon-Gibod I, Laurent J, Martin L, et al. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. Ann Allergy Asthma Immunol. 2013;111:290–4.CrossRefPubMed
28.
Lumry WR, Miller DP, Newcomer S, Fitts D, Dayno J. Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks. Allergy Asthma Proc. 2014;35:371–6.CrossRefPubMed
29.
Mozaffari H, Pourpak Z, Pourseyed S, Moin M, Farhoodi A. Health-related quality of life in primary immune deficient patients. Iran J Allergy Asthma Immunol. 2006;5:23–7.PubMed
30.
Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.CrossRefPubMed
31.
Abolhassani H, Aghamohammadi A, Pourjabbar S, Sadaghiani MS, Nikayin S, Rabiee A, et al. Psychiatric aspects of primary immunodeficiency diseases: the parental study. Iran J Allergy Asthma Immunol. 2013;12:176–81.PubMed
32.
Madeo AC, O’Brien KE, Ba B, Biesecker BB. Factors associated with perceived uncertainty among parents of children with undiagnosed medical conditions. Am J Med Genet A. 2012;158(A):1877–84.CrossRef
33.
Lipinski SE, Lipinski MJ, Biesecker LG, Biesecker BB. Uncertainty and perceived personal control among parents of children with rare chromosome conditions: the role of genetic counseling. Am J Med Genet C: Semin Med Genet. 2006;142C:232–40.CrossRef
34.
Lenhard W, Breitenbach E, Ebert H, Schindelhauer-Deutscher HJ, Henn W. Psychological benefit of diagnostic certainty for mothers of children with disabilities: lessons from down syndrome. Am J Med Genet. 2005;133(A):170–5.CrossRef
35.
Milner JD, Holland SM. The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol. 2013;13:635–48.CrossRefPubMed
36.
Kuburovic N, Pasic S, Stevanovic D, Kuburovic V, Zdravkovic S, Petrovic M, et al. Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies. Patient Prefer Adherence. 2014;8:323–30.PubMedCentralCrossRefPubMed
37.
Tabolli S, Giannantoni P, Pulvirenti F, La Marra F, Granata G, Milito C, et al. Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies. Front Immunol. 2014;5:1–9.CrossRef
38.
Quinti I, Di Pietro C, Martini H, Pesce AM, Lombardi F, Baumghartner M, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J. 2012;53:603–10.PubMedCentralCrossRefPubMed
39.
Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet A. 2010:1136–56.
40.
Martin S, Wolters P, Billings N, Toledo-Tamula MA, Hammoud DA, Welch P, et al. Neurobehavioral profiles in individuals with hyperimmunoglobulin E syndrome (HIES) and brain white matter hyperintensities. J Clin Immunol. 2013;33:1175–84.CrossRefPubMed
41.
Briegel W, Schneider M, Schwab KO. 22Q11.2 deletion syndrome: behaviour problems of children and adolescents and parental stress. Child Care Health Dev. 2008;34:795–800.PubMed
42.
Tcheurekdjian H, Palermo T, Hostoffer R. Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2004;93:160–5.CrossRef
43.
Zebracki K, Palermo TM, Hostoffer R, Duff K, Drotar D. Health-related quality of life of children with primary immunodeficiency disease: a comparison study. Ann Allergy Asthma Immunol. 2004;93:557–61.CrossRefPubMed
44.
Soresina A, Nacinovich R, Bomba M, Cassani M, Molinaro A, Sciotto A, et al. The quality of life of children and adolescents with X-linked agammaglobulinemia. J Clin Immunol. 2009;29:501–7.CrossRefPubMed
45.
Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. J Clin Immunol. 2013;33:8–13.CrossRefPubMed
46.
Skucek E, Butler S, Gaspar H, Titman P. Social outcome in children treated by haematopoietic cell transplant for congenital immunodeficiency. Bone Marrow Transplant. 2011;46:1314–20.CrossRefPubMed
47.
De Civita M, Regier D, Alamgir A, Anis A, Fitzgerald M, Marra C. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics. 2005;23:659–85.CrossRefPubMed
48.
Lazarus R, Folkman S. Stress, appraisal, and coping. 1984.
Metadaten
Titel
Life with a Primary Immune Deficiency: a Systematic Synthesis of the Literature and Proposed Research Agenda
verfasst von
Morgan N. Similuk
Angela Wang
Michael J. Lenardo
Lori H. Erby
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2016
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0241-1

Weitere Artikel der Ausgabe 2/2016

Journal of Clinical Immunology 2/2016 Zur Ausgabe

Letter to Editor

Autosomal Dominant Hyper IgE Syndrome – Treatment Strategies and Clinical Outcomes

Original Article

Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey

Letter to Editor

Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?

Letter to Editor

An infant with ZAP-70 deficiency with disseminated mycobacterial disease

Original Article

Risk of Infections Among 2100 Individuals with IgA Deficiency: a Nationwide Cohort Study

Letter to Editor

TNFA, ANXA11 and BTNL2 Polymorphisms in CVID Patients with Granulomatous Disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir nicht substanzbedingt Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise